Certified by Founder Lodge
Boundless Bio
United States - La Jolla, California
START UP
1 Disclosed Funding Rounds $100,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.
When DNA in can
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 17 ,2023 | Series C | $100,000,000 |
ARCH Venture Partners
Vertex Ventures HC
Alexandria Real Estate Equities, Inc.
Wellington Management
Nextech Invest
RA Capital Management, L.P.
GT Healthcare Capital Partners
Sectoral Asset Management
Logos Capital
PFM Health Sciences
Redmile Group
Surveyor Capital
Leaps by Bayer
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
